Trinity Biotech (TRIB) Receivables - Other (2023 - 2025)

Trinity Biotech's Receivables - Other history runs 3 years deep, the most recent figure standing at $16000.0 for Q4 2025.

• In Q4 2025, Receivables - Other fell 90.48% year-over-year to $16000.0; the TTM figure through Dec 2025 stood at $16000.0 (down 90.48% YoY), while the FY2025 annual figure was $16000.0, down 90.48% from the prior year.
• Receivables - Other came in at $16000.0 for Q4 2025 at Trinity Biotech, down from $168000.0 in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $168000.0 in Q4 2024 to a low of $16000.0 in Q4 2025.
• A 3-year average of $97000.0 and a median of $107000.0 in 2023 frame the typical range for Receivables - Other.
• Across the five-year window, Receivables - Other surged 57.01% in 2024 and tumbled 90.48% in 2025, its largest moves.
• Trinity Biotech's Receivables - Other stood at $107000.0 in 2023, then soared by 57.01% to $168000.0 in 2024, then sank by 90.48% to $16000.0 in 2025.
• According to Business Quant data, Receivables - Other over the past three periods registered $16000.0, $168000.0, and $107000.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.

Peer Comparison